108 related articles for article (PubMed ID: 7956711)
1. Acceleration of diabetes in young NOD mice with peritoneal macrophages.
Shimada A; Takei I; Maruyama T; Kasuga A; Kasatani T; Watanabe K; Asaba Y; Ishii T; Tadakuma T; Habu S
Diabetes Res Clin Pract; 1994 Jun; 24(2):69-76. PubMed ID: 7956711
[TBL] [Abstract][Full Text] [Related]
2. Assessment of beta cell mass and oxidative peritoneal exudate cells in murine type 1 diabetes using adoptive transfer system.
Yamada S; Irie J; Shimada A; Kodama K; Morimoto J; Suzuki R; Oikawa Y; Saruta T
Autoimmunity; 2003 Mar; 36(2):63-70. PubMed ID: 12820687
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
4. The role of cytotoxic macrophages in non-obese diabetic mice: cytotoxicity against murine mastocytoma and beta-cell lines.
Kasuga A; Maruyama T; Takei I; Shimada A; Kasatani T; Watanabe K; Saruta T; Nakaki T; Habu S; Miyazaki J
Diabetologia; 1993 Dec; 36(12):1252-7. PubMed ID: 8307252
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide is important for mouse beta-cell line killing by peritoneal exudate cells obtained from cyclophosphamide treated non-obese diabetic mice.
Kasuga A; Nakaki T; Takei I; Takayama S; Ozawa Y; Maruyama T; Miyazaki J; Saruta T
Endocr J; 1995 Apr; 42(2):259-63. PubMed ID: 7542976
[TBL] [Abstract][Full Text] [Related]
6. Relationship between beta cell mass of NOD donors and diabetes development of NOD-scid recipients in adoptive transfer system.
Yamada S; Shimada A; Kodama K; Morimoto J; Suzuki R; Oikawa Y; Irie J; Saruta T
Ann N Y Acad Sci; 2003 Nov; 1005():211-4. PubMed ID: 14679061
[TBL] [Abstract][Full Text] [Related]
7. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
Takahashi K; Satoh J; Sagara M; Zhu XP; Muto G; Muto Y; Fukuzawa M; Nishimura S; Miyaguchi S; Toyata T
J Autoimmun; 1995 Jun; 8(3):335-46. PubMed ID: 7575995
[TBL] [Abstract][Full Text] [Related]
8. Prevention of overt diabetes and insulitis by intrathymic injection of syngeneic islets in newborn nonobese diabetic (NOD) mice.
Nomura Y; Stein E; Mullen Y
Transplantation; 1993 Sep; 56(3):638-42. PubMed ID: 8212162
[TBL] [Abstract][Full Text] [Related]
9. Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice.
Fujihira K; Nagata M; Moriyama H; Yasuda H; Arisawa K; Nakayama M; Maeda S; Kasuga M; Okumura K; Yagita H; Yokono K
Diabetes; 2000 Dec; 49(12):1998-2006. PubMed ID: 11118000
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice.
Jansen A; Homo-Delarche F; Hooijkaas H; Leenen PJ; Dardenne M; Drexhage HA
Diabetes; 1994 May; 43(5):667-75. PubMed ID: 8168644
[TBL] [Abstract][Full Text] [Related]
11. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
Saï P; Rivereau AS; Granier C; Haertlé T; Martignat L
Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
[TBL] [Abstract][Full Text] [Related]
12. NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice.
Prochazka M; Serreze DV; Frankel WN; Leiter EH
Diabetes; 1992 Jan; 41(1):98-106. PubMed ID: 1727742
[TBL] [Abstract][Full Text] [Related]
13. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
14. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus.
Charlton B; Bacelj A; Slattery RM; Mandel TE
Diabetes; 1989 Apr; 38(4):441-7. PubMed ID: 2522407
[TBL] [Abstract][Full Text] [Related]
16. Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior.
Hänninen A; Salmi M; Simell O; Jalkanen S
Diabetes; 1996 Sep; 45(9):1173-80. PubMed ID: 8772718
[TBL] [Abstract][Full Text] [Related]
17. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway.
Ablamunits V; Quintana F; Reshef T; Elias D; Cohen IR
J Autoimmun; 1999 Dec; 13(4):383-92. PubMed ID: 10585754
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.
Hermitte L; Vialettes B; Naquet P; Atlan C; Payan MJ; Vague P
Eur J Immunol; 1990 Jun; 20(6):1297-303. PubMed ID: 2164479
[TBL] [Abstract][Full Text] [Related]
19. Induction of anti-whole GAD65 reactivity in vivo results in disease suppression in type 1 diabetes.
Kanazawa Y; Shimada A; Oikawa Y; Okubo Y; Tada A; Imai T; Miyazaki J; Itoh H
J Autoimmun; 2009 Mar; 32(2):104-9. PubMed ID: 19188044
[TBL] [Abstract][Full Text] [Related]
20. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice.
Rohane PW; Shimada A; Kim DT; Edwards CT; Charlton B; Shultz LD; Fathman CG
Diabetes; 1995 May; 44(5):550-4. PubMed ID: 7729614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
